AFG
Albion Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608 | Hold |
120
| – | – | ﹤0.01% | 539 |
|
|
2025
Q1 | $635 | Hold |
120
| – | – | ﹤0.01% | 555 |
|
|
2024
Q4 | $812 | Hold |
120
| – | – | ﹤0.01% | 622 |
|
|
2024
Q3 | $791 | Hold |
120
| – | – | ﹤0.01% | 464 |
|
|
2024
Q2 | $900 | Hold |
120
| – | – | ﹤0.01% | 463 |
|
|
2024
Q1 | $1.2K | Hold |
120
| – | – | ﹤0.01% | 442 |
|
|
2023
Q4 | $1.18K | Hold |
120
| – | – | ﹤0.01% | 419 |
|
|
2023
Q3 | $918 | Hold |
120
| – | – | ﹤0.01% | 425 |
|
|
2023
Q2 | $897 | Sell |
120
-4,063
| -97% | -$30.4K | ﹤0.01% | 421 |
|
|
2023
Q1 | $27.9K | Hold |
4,183
| – | – | ﹤0.01% | 236 |
|
|
2022
Q4 | $32.3K | Buy |
4,183
+1
| +0% | +$8 | ﹤0.01% | 231 |
|
|
2022
Q3 | $44K | Buy |
4,182
+4,062
| +3,385% | +$42.7K | ﹤0.01% | 218 |
|
|
2022
Q2 | $1K | Hold |
120
| – | – | ﹤0.01% | 503 |
|
|
2022
Q1 | $1K | Sell |
120
-6,094
| -98% | -$50.8K | ﹤0.01% | 569 |
|
|
2021
Q4 | $106K | Buy |
+6,214
| New | +$106K | 0.01% | 243 |
|